Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Varsha Gandhi, PhD, on Ibrutinib

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Advertisement

Advertisement




Jul
12
Today In Oncology
New Research Offers Reassurance About Localized Prostate Cancer Prognosis
Avelumab Plus Cetuximab in Advanced Cutaneous Squamous Cell Carcinoma
Surgery vs Ablation in Small Hepatocellular Carcinoma
Chemoimmunotherapy for Advanced BTC 3-Year Overall Survival Update From the TOPAZ Trial
Optimizing the CAR to the Disease in B-Cell Malignancies
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo